A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Completed · Phase 2 · Has a placebo group

Conditions studied: Non-Alcoholic Steatohepatitis

In brief

The purpose of this study is to determine whether BMS-986036 is effective in the treatment of subjects with Non-alcoholic Steatohepatitis (NASH).

Key facts

Study ID
NCT02413372
Run by
Bristol-Myers Squibb
People needed
184
Starts
2015-05-08
Expected to finish
2017-06-19
Last updated by the study team
2021-02-26

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.